SEC FORM 4
$502,036.82
UNITED THERAPEUTICS Corp (UTHR)
Sale of 920 shares at $545.6922 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →